| Intrinsic Valuation of: EQIX | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 10 | Market Cap | $78B | |||||
| 2021 | - | - (-) | P/E Ratio | 83 | Total Asset | $35B | |||||
| 2022 | $-204M | - (-) | Net Income | $815M | Total Debt | $14B | |||||
| 2023 | $685M | 435.3% (406.3%) | EBITDA | $3B | Total Liab | $22B | |||||
| 2024 | $436M | -36.4% (-43.5%) | Opr Margin | 0.19 | Debt/Equity | 1.03 | |||||
| 2025 | $183M | -58.0% (-60.7%) | PreTax Margin | 13.34 | BV/Share | 68 | |||||
| 5Y Average FCF | $275M | 113.6% (100.7%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (25.0%) | ||||||||||
| 2026 | $229M | MBG Intrinsic Value | $85 | ||||||||
| 2027 | $286M | ||||||||||
| 2028 | $357M | ||||||||||
| 2029 | $447M | ||||||||||
| 2030 | $558M | ||||||||||
| 2031 | $698M | ||||||||||
| Terminal Value | $15B | Net Worth/Share | $139 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $11B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $3B | $5 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $14B | WACC | 7.3% | -11 | -3 | 7 | 19 | 34 | |||
| Equity Value | $444M | 7.4% | -12 | -4 | 6 | 18 | 32 | ||||
| Shares Outstanding | 97,819,000 | 7.4% | -13 | -5 | 5 | 16 | 30 | ||||
| 7.9% | -21 | -15 | -7 | 2 | 13 | ||||||
| DCF Intrinsic Value | $5 | 8.4% | -28 | -23 | -17 | -9 | -0 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||